combretastatin A 1 diphosphate

combretastatin A 1 diphosphate
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2012-11-19 00:00:00
Sponsor Mateon Therapeutics, Inc.;701 Gateway Blvd, Suite 210;South San Francisco, California, 94080
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia